Seeing the Forest Through the Trees:
Therapeutic Approaches for Hospitalized Patients with COVID-19
*** Expert Roundtable ***
Post-Survey & Application for CME Credit

In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 75% on this post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.
1.HCPs: What are your credentials? (Required.)
2.What is your community of practice?
3.65yo M 🚬 w/ BMI of 35 
Hx of HTN, PAD, HLD, COPD c/o fever & cough X 4 days
SpO2=95 on room air
Crackles in left🫁
Rescue med for SOB not working
Vaccinated + boosted for COVID 6m prior
Opacities on CXR in both🫁; 50% affected

📊What next? 
(Required.)
4.NIH guidelines recommend the following agents for a hospitalized patient on conventional O2 supplementation at risk for disease progression(Required.)
5.Which of the following correlated with more severe COVID disease?
6.What types of trials are providing timely new evidence for COVID-19 therapeutics?
EVALUATION FORM
7.Upon completion of this activity, I am better able to:
Strongly agree
Agree
Disagree
Strongly disagree
REVIEW and understand the evidence basis for updated guidance on COVID-19 therapeutics
SELECT appropriate treatment regimens based on the severity of COVID-19 illness
RELATE the significance of high plasma viral loads to disease severity and patient outcomes
RECOGNIZE gaps and unmet needs within current treatments, treatment approaches, and emerging therapies for hospitalized patients with COVID-19
8.Please rate how well the activity:
Strongly agree
Agree
Disagree
Strongly disagree
Met your educational needs
Reinforced and/or improved your current skills
Gave you tools and/or strategies to apply in your practice
Improved your ability to treat and/or manage your patients
Utilized faculty w/ expertise in the area: Onyema Ogbuagu, MD
Utilized faculty w/ expertise in the area: Nida Qadir, MD
Utilized faculty w/ expertise in the area: Charlie Wray, DO
9.Please rate  if the activity:
Yes
No
Was fair, balanced and free from commercial bias (Commercial bias is defined as promoting a specific proprietary business interest of a commercial entity, and/or not including a balanced view of therapeutic options)
Addressed strategies for overcoming barriers to optimal patient care (e.g. access to care, cost, etc…)
Provided content that was evidence-based and clinically relevant
10.Of the patients you will see in the next month, about how many will benefit from the information you learned today?
11.Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):
12.Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
13.Is there anything else you would like to communicate to us about this activity? 
14.For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*(Required.)
15.I certify that I have participated in the continuing education activity entitled, "Seeing the Forest Through the Trees: Therapeutic Approaches for Hospitalized Patients with COVID-19 - Expert Roundtable" and claim1.25 AMA PRA Category 1 CreditsTM.(Required.)
Thank you for participating in our activity and completing the necessary paperwork. Please allow 4-6 weeks to receive your certificate. For information about the certification of this program, please contact National Jewish Health at proed@njhealth.org.
Privacy & Cookie Notice